1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Kang, R.S.
Daniels, C.M.
Salerno, W.J.
Radhakrishnan, I.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
US
Cell(Cambridge,Mass.)
CELLB5
0998
0092-8674
113
621
630
10.1016/S0092-8674(03)00362-3
12787503
Solution Structure of a CUE-Ubiquitin Complex Reveals a Conserved Mode
of Ubiquitin Binding
2003
10.2210/pdb1otr/pdb
pdb_00001otr
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
5573.291
protein Cue2
Amino-terminal CUE Domain, Residues 6-54
1
man
polymer
8568.769
Ubiquitin
1
man
polymer
HYPOTHETICAL 50.9 KD PROTEIN IN BUD2-MIF2 INTERGENIC REGION; hypothetical protein YKL090w
no
no
NDDHESKLSILMDMFPAISKSKLQVHLLENNNDLDLTIGLLLKENDDKS
NDDHESKLSILMDMFPAISKSKLQVHLLENNNDLDLTIGLLLKENDDKS
A
polypeptide(L)
no
no
MQIFVKTLTGKTITLEVESSDTIDNVKSKIQDKEGIPPDQQRLIFAGKQLEDGRTLSDYNIQKESTLHLVLRLRGG
MQIFVKTLTGKTITLEVESSDTIDNVKSKIQDKEGIPPDQQRLIFAGKQLEDGRTLSDYNIQKESTLHLVLRLRGG
B
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
baker's yeast
Saccharomyces
Escherichia
Escherichia coli
sample
CUE2
4932
Saccharomyces cerevisiae
469008
Escherichia coli BL21(DE3)
BL21(DE3)
PLASMID
pMCSG
baker's yeast
Saccharomyces
Escherichia
Escherichia coli
sample
UBI1
4932
Saccharomyces cerevisiae
469008
Escherichia coli BL21(DE3)
BL21(DE3)
PLASMID
pET-3a
database_2
pdbx_nmr_software
pdbx_struct_assembly
pdbx_struct_oper_list
repository
Initial release
Version format compliance
Version format compliance
Data collection
Database references
Derived calculations
1
0
2003-06-24
1
1
2008-04-29
1
2
2011-07-13
1
3
2022-02-23
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_nmr_software.name
RCSB
Y
RCSB
2003-03-22
REL
The submitted conformer models are the 20 structures with the lowest
restraint energies, restraint violations, and RMS deviations from
ideal covalent geometry
80
20
3D_15N-separated_NOESY
3D_13C-separated_NOESY
3D_13C-filtered,_13C-edited_NOESY
2D_DOUBLE_HALF-FILTERED_NOESY
20 mM sodium phosphate, pH 7.0, 0.2% NaN3
7.0
1
atm
298
K
The structures are based on a total of 3328 distance restraints,
including 3238 NOE-derived distance restraints [2560 unambiguous
and 678 ambiguous restraints], 90 hydrogen bonding distance restraints,
and 150 torsion angle restraints.
torsion angle dynamics and simulated annealing
1
closest to the average
1 mM U-15N,13C Cue2 + 1 mM Ubiquitin; 20 mM sodium phosphate buffer, pH 7.0, 0.2% NaN3
90% H2O/10% D2O
1 mM U-15N,13C Cue2 + 1 mM Ubiquitin; 20 mM sodium phosphate buffer, pH 7.0, 0.2% NaN3
99.996% D2O
1 mM Cue2 + 1 mM U-15N,13C Ubiquitin; 20 mM sodium phosphate buffer, pH 7.0, 0.2% NaN3
90% H2O/10% D2O
1 mM Cue2 + 1 mM U-15N,13C Ubiquitin; 20 mM sodium phosphate buffer, pH 7.0, 0.2% NaN3
99.996% D2O
Varian
collection
VNMR
6.1b
Accelrys
processing
Felix
98.0 and 2000
Accelrys
data analysis
Felix
98.0 and 2000
Brunger et al.
structure solution
CNS
1.1
Linge and Nilges
structure solution
ARIA
1.2
Linge and Nilges
refinement
ARIA
1.2
Brunger et al.
refinement
CNS
1.1
600
Varian
INOVA
ASN
6
n
1
ASN
6
A
ASP
7
n
2
ASP
7
A
ASP
8
n
3
ASP
8
A
HIS
9
n
4
HIS
9
A
GLU
10
n
5
GLU
10
A
SER
11
n
6
SER
11
A
LYS
12
n
7
LYS
12
A
LEU
13
n
8
LEU
13
A
SER
14
n
9
SER
14
A
ILE
15
n
10
ILE
15
A
LEU
16
n
11
LEU
16
A
MET
17
n
12
MET
17
A
ASP
18
n
13
ASP
18
A
MET
19
n
14
MET
19
A
PHE
20
n
15
PHE
20
A
PRO
21
n
16
PRO
21
A
ALA
22
n
17
ALA
22
A
ILE
23
n
18
ILE
23
A
SER
24
n
19
SER
24
A
LYS
25
n
20
LYS
25
A
SER
26
n
21
SER
26
A
LYS
27
n
22
LYS
27
A
LEU
28
n
23
LEU
28
A
GLN
29
n
24
GLN
29
A
VAL
30
n
25
VAL
30
A
HIS
31
n
26
HIS
31
A
LEU
32
n
27
LEU
32
A
LEU
33
n
28
LEU
33
A
GLU
34
n
29
GLU
34
A
ASN
35
n
30
ASN
35
A
ASN
36
n
31
ASN
36
A
ASN
37
n
32
ASN
37
A
ASP
38
n
33
ASP
38
A
LEU
39
n
34
LEU
39
A
ASP
40
n
35
ASP
40
A
LEU
41
n
36
LEU
41
A
THR
42
n
37
THR
42
A
ILE
43
n
38
ILE
43
A
GLY
44
n
39
GLY
44
A
LEU
45
n
40
LEU
45
A
LEU
46
n
41
LEU
46
A
LEU
47
n
42
LEU
47
A
LYS
48
n
43
LYS
48
A
GLU
49
n
44
GLU
49
A
ASN
50
n
45
ASN
50
A
ASP
51
n
46
ASP
51
A
ASP
52
n
47
ASP
52
A
LYS
53
n
48
LYS
53
A
SER
54
n
49
SER
54
A
MET
1
n
1
MET
1
B
GLN
2
n
2
GLN
2
B
ILE
3
n
3
ILE
3
B
PHE
4
n
4
PHE
4
B
VAL
5
n
5
VAL
5
B
LYS
6
n
6
LYS
6
B
THR
7
n
7
THR
7
B
LEU
8
n
8
LEU
8
B
THR
9
n
9
THR
9
B
GLY
10
n
10
GLY
10
B
LYS
11
n
11
LYS
11
B
THR
12
n
12
THR
12
B
ILE
13
n
13
ILE
13
B
THR
14
n
14
THR
14
B
LEU
15
n
15
LEU
15
B
GLU
16
n
16
GLU
16
B
VAL
17
n
17
VAL
17
B
GLU
18
n
18
GLU
18
B
SER
19
n
19
SER
19
B
SER
20
n
20
SER
20
B
ASP
21
n
21
ASP
21
B
THR
22
n
22
THR
22
B
ILE
23
n
23
ILE
23
B
ASP
24
n
24
ASP
24
B
ASN
25
n
25
ASN
25
B
VAL
26
n
26
VAL
26
B
LYS
27
n
27
LYS
27
B
SER
28
n
28
SER
28
B
LYS
29
n
29
LYS
29
B
ILE
30
n
30
ILE
30
B
GLN
31
n
31
GLN
31
B
ASP
32
n
32
ASP
32
B
LYS
33
n
33
LYS
33
B
GLU
34
n
34
GLU
34
B
GLY
35
n
35
GLY
35
B
ILE
36
n
36
ILE
36
B
PRO
37
n
37
PRO
37
B
PRO
38
n
38
PRO
38
B
ASP
39
n
39
ASP
39
B
GLN
40
n
40
GLN
40
B
GLN
41
n
41
GLN
41
B
ARG
42
n
42
ARG
42
B
LEU
43
n
43
LEU
43
B
ILE
44
n
44
ILE
44
B
PHE
45
n
45
PHE
45
B
ALA
46
n
46
ALA
46
B
GLY
47
n
47
GLY
47
B
LYS
48
n
48
LYS
48
B
GLN
49
n
49
GLN
49
B
LEU
50
n
50
LEU
50
B
GLU
51
n
51
GLU
51
B
ASP
52
n
52
ASP
52
B
GLY
53
n
53
GLY
53
B
ARG
54
n
54
ARG
54
B
THR
55
n
55
THR
55
B
LEU
56
n
56
LEU
56
B
SER
57
n
57
SER
57
B
ASP
58
n
58
ASP
58
B
TYR
59
n
59
TYR
59
B
ASN
60
n
60
ASN
60
B
ILE
61
n
61
ILE
61
B
GLN
62
n
62
GLN
62
B
LYS
63
n
63
LYS
63
B
GLU
64
n
64
GLU
64
B
SER
65
n
65
SER
65
B
THR
66
n
66
THR
66
B
LEU
67
n
67
LEU
67
B
HIS
68
n
68
HIS
68
B
LEU
69
n
69
LEU
69
B
VAL
70
n
70
VAL
70
B
LEU
71
n
71
LEU
71
B
ARG
72
n
72
ARG
72
B
LEU
73
n
73
LEU
73
B
ARG
74
n
74
ARG
74
B
GLY
75
n
75
GLY
75
B
GLY
76
n
76
GLY
76
B
author_defined_assembly
2
dimeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
B
O
LEU
15
B
O
LEU
15
B
N
ILE
3
B
N
ILE
3
B
N
PHE
4
B
N
PHE
4
B
O
LEU
67
B
O
LEU
67
B
O
HIS
68
B
O
HIS
68
B
N
ILE
44
B
N
ILE
44
B
N
PHE
45
B
N
PHE
45
B
O
LYS
48
B
O
LYS
48
1
A
ASP
7
-151.63
-39.04
1
A
ASP
8
-150.67
39.48
1
A
ALA
22
-163.53
-41.22
1
A
ASN
35
-77.74
33.65
1
A
ASN
50
-79.87
45.78
1
A
ASP
52
-176.67
134.98
1
B
ASP
21
-83.06
-126.88
1
B
LYS
48
-173.19
138.94
1
B
GLN
62
-76.75
-154.64
1
B
ARG
74
59.27
-141.22
2
A
ASP
8
-174.81
54.60
2
A
ALA
22
-168.37
-44.38
2
A
ASN
36
64.57
-72.96
2
A
ASN
37
-162.09
-30.33
2
A
ASP
38
-39.27
123.04
2
A
LYS
48
-80.83
43.00
2
A
ASN
50
-81.05
39.74
2
A
ASP
52
63.97
129.89
2
B
ASP
21
-84.29
-123.38
2
B
THR
22
-171.72
141.35
2
B
TYR
59
-85.74
31.91
2
B
LYS
63
-179.93
140.74
2
B
ARG
74
64.31
133.34
3
A
ASP
7
75.78
-47.19
3
A
ALA
22
-165.74
-39.76
3
A
ASN
35
-81.23
38.69
3
A
LYS
48
-78.93
39.77
3
A
ASN
50
-90.07
41.60
3
A
ASP
51
-176.15
133.95
3
A
ASP
52
-171.09
132.94
3
B
LYS
11
-164.68
116.12
3
B
SER
20
-92.39
36.60
3
B
ASP
21
-80.52
-134.04
3
B
THR
22
-175.94
143.70
3
B
GLU
34
-140.40
-32.19
3
B
ALA
46
69.43
-34.25
3
B
LEU
50
-82.87
35.96
3
B
GLU
51
51.16
-167.26
3
B
ARG
74
-173.63
46.87
4
A
ASP
7
69.30
138.12
4
A
ASP
8
-76.06
40.03
4
A
ALA
22
-166.93
-42.93
4
A
ASN
35
-77.64
37.48
4
A
ASN
50
-69.62
-133.15
4
A
ASP
51
71.79
-24.32
4
A
LYS
53
-169.57
-43.31
4
B
LEU
8
-42.60
102.13
4
B
LYS
11
-172.88
139.28
4
B
SER
19
-77.35
43.54
4
B
SER
20
-168.58
49.68
4
B
LEU
43
-69.55
86.60
4
B
LYS
48
-173.27
144.18
5
A
ASP
7
-170.16
-30.77
5
A
ASP
8
-166.50
43.11
5
A
ASN
36
65.41
-71.00
5
A
ASN
37
-177.09
32.96
5
A
LYS
48
-81.47
40.78
5
B
SER
19
-76.62
30.05
5
B
ASP
21
-61.20
-113.98
5
B
THR
22
-170.12
146.32
5
B
LYS
48
-173.02
138.69
5
B
ARG
54
-67.21
-140.91
5
B
SER
65
-72.72
-151.29
6
A
ASP
7
-176.35
-44.23
6
A
ASP
8
-142.24
45.17
6
A
PRO
21
-80.36
49.87
6
A
ALA
22
-168.36
-44.15
6
A
ASN
35
-78.78
44.21
6
A
GLU
49
-75.34
31.77
6
A
ASN
50
-145.76
46.72
6
A
ASP
51
-169.93
-45.23
6
A
ASP
52
58.00
-133.03
6
B
THR
7
-77.02
-148.36
6
B
LEU
8
-108.38
48.50
6
B
THR
9
-160.60
-52.27
6
B
ASP
21
-84.43
-124.61
6
B
LYS
48
-172.36
143.29
6
B
ARG
54
-64.67
-145.08
6
B
GLN
62
-85.35
-157.80
7
A
ASP
7
-172.15
-40.05
7
A
ASP
8
-176.20
40.89
7
A
ASN
35
-83.94
36.53
7
A
ASN
36
64.22
-74.68
7
A
ASN
37
179.32
28.97
7
A
ASP
52
-175.22
128.00
7
A
LYS
53
-177.97
-46.53
7
B
THR
7
-70.23
-150.66
7
B
LEU
8
-105.78
41.86
7
B
THR
9
-150.15
-53.37
7
B
ASP
21
-77.13
-126.01
7
B
THR
22
-174.73
140.48
7
B
GLN
62
-80.95
-141.79
8
A
ASP
8
-172.54
45.12
8
A
ALA
22
-77.08
32.97
8
A
ASN
35
-79.66
35.64
8
A
LYS
48
-87.20
34.55
8
A
ASN
50
-80.77
48.84
8
B
THR
9
-158.01
-55.37
8
B
LYS
11
-161.57
115.43
8
B
VAL
17
-177.23
131.17
8
B
SER
20
-80.26
35.61
8
B
ASP
21
-99.65
-122.15
8
B
THR
22
-172.55
140.74
8
B
ASP
39
-83.29
40.24
8
B
GLN
40
-162.19
35.23
8
B
GLN
41
-171.37
146.35
8
B
ALA
46
69.81
-64.48
8
B
TYR
59
-82.46
30.96
8
B
LYS
63
179.20
148.64
9
A
ASP
7
75.57
-42.32
9
A
ASN
35
-61.92
-71.03
9
A
ASN
36
167.76
42.27
9
B
LEU
8
-48.04
87.59
9
B
SER
19
-77.68
42.30
9
B
SER
20
-166.71
38.80
9
B
ASP
21
-108.03
-120.78
9
B
ALA
46
70.89
-30.64
9
B
LEU
50
-75.45
44.14
9
B
GLU
51
51.67
-166.59
9
B
ASP
52
-145.40
52.12
9
B
ARG
54
-141.11
-144.00
9
B
GLN
62
-66.86
-114.90
9
B
ARG
74
57.29
-86.06
10
A
ASP
7
-167.86
-143.93
10
A
ALA
22
-161.75
-46.83
10
A
ASN
35
-79.36
28.83
10
A
ASN
36
63.12
-72.62
10
A
ASN
37
178.09
72.65
10
A
LYS
48
-82.92
43.17
10
A
ASN
50
-157.32
48.37
10
B
LYS
11
177.67
117.26
10
B
SER
19
-76.09
27.56
10
B
SER
20
-165.10
28.06
10
B
ASP
21
-76.09
-121.71
10
B
THR
22
-173.77
138.71
10
B
ARG
72
-72.23
-116.26
10
B
ARG
74
-67.98
-141.64
11
A
ASP
8
-166.89
33.88
11
A
ALA
22
-166.92
-44.96
11
A
ASN
35
-85.12
32.24
11
A
ASN
36
64.90
-71.89
11
A
ASN
37
-179.09
33.45
11
A
LYS
48
-81.36
41.22
11
A
ASN
50
-164.22
-50.40
11
A
ASP
51
54.69
-132.65
11
A
ASP
52
66.47
136.57
11
B
SER
20
-97.84
35.57
11
B
ASP
21
-83.45
-126.22
11
B
THR
22
-172.94
143.51
11
B
LYS
48
-173.11
146.11
11
B
ARG
74
-149.02
-45.06
12
A
ASP
7
-173.91
-147.95
12
A
ASP
8
-83.20
33.61
12
A
PRO
21
-80.31
49.98
12
A
ALA
22
-168.19
-42.88
12
A
ASN
35
-82.70
35.93
12
A
ASN
36
63.29
-72.78
12
A
ASN
37
-178.95
34.40
12
A
ASN
50
-84.02
36.72
12
A
ASP
51
-78.86
-146.95
12
A
LYS
53
-175.97
133.36
12
B
ASP
21
-59.89
-121.43
12
B
LYS
48
-172.74
137.35
12
B
ARG
54
-66.23
-143.21
13
A
ASP
7
-157.20
-47.27
13
A
ASP
8
-174.22
103.99
13
A
ALA
22
-165.71
-48.14
13
A
ASN
35
-83.71
32.38
13
A
ASN
36
64.75
-72.82
13
A
ASN
37
-177.92
31.21
13
A
LYS
48
-82.98
42.36
13
A
ASN
50
-70.46
-144.50
13
A
ASP
51
55.37
-122.19
13
A
ASP
52
63.27
120.46
13
B
SER
20
-82.18
49.86
13
B
LYS
33
-68.84
-72.45
13
B
ALA
46
70.52
-32.97
13
B
GLN
62
-84.02
-155.47
13
B
SER
65
-73.75
-152.83
13
B
ARG
72
-63.02
-72.94
13
B
ARG
74
57.85
-112.40
14
A
ASP
7
65.21
139.53
14
A
ASP
8
-167.96
41.06
14
A
ALA
22
-166.98
-42.97
14
A
ASN
35
-77.29
34.55
14
A
LYS
48
-77.18
30.13
14
A
ASN
50
-79.81
46.43
14
A
ASP
52
-77.62
43.35
14
B
LYS
11
-162.13
118.54
14
B
ASP
21
-79.33
-128.82
14
B
THR
22
-175.03
140.46
14
B
LYS
33
-73.68
-76.66
14
B
ASP
39
-78.92
33.89
14
B
GLN
40
-161.29
31.60
14
B
LYS
48
-172.71
142.48
14
B
GLN
62
-74.97
-138.50
14
B
ARG
72
-68.12
-105.48
14
B
ARG
74
-68.34
-135.10
15
A
ASP
7
-69.11
-123.87
15
A
ALA
22
-165.81
-39.39
15
A
ASN
35
-64.73
-76.10
15
A
ASN
36
171.08
36.04
15
A
ASP
51
-177.19
128.60
15
A
ASP
52
-83.22
41.74
15
A
LYS
53
57.17
-120.66
15
B
SER
20
-90.73
33.07
15
B
ASP
21
-83.67
-141.22
15
B
GLN
40
-79.09
35.44
15
B
ALA
46
68.11
-31.54
15
B
ASP
52
-76.37
46.35
15
B
SER
65
-80.30
-148.27
15
B
ARG
72
57.19
166.69
15
B
LEU
73
-74.83
-147.91
16
A
PHE
20
-113.85
76.97
16
A
ALA
22
-165.20
-43.07
16
A
ASN
35
-76.87
40.03
16
A
LYS
48
-81.35
41.71
16
A
ASP
51
65.94
132.51
16
B
SER
19
-77.29
42.20
16
B
SER
20
-160.44
40.45
16
B
ASP
21
-121.56
-121.56
16
B
LYS
33
-73.09
-76.83
16
B
GLN
40
-89.52
38.15
16
B
ALA
46
68.98
-65.27
16
B
ASP
52
-77.88
46.54
17
A
ASP
8
-155.32
34.87
17
A
ASN
36
172.47
-63.29
17
A
ASN
37
173.43
33.01
17
A
LYS
48
-82.08
39.54
17
A
ASP
51
-163.07
-44.21
17
B
SER
19
-77.15
41.52
17
B
SER
20
-163.53
32.99
17
B
ASP
21
-98.20
-122.35
17
B
LYS
48
-173.14
144.56
17
B
GLN
62
-85.10
-155.00
17
B
SER
65
-69.38
-151.51
17
B
ARG
72
-75.12
-134.24
17
B
ARG
74
-168.15
47.22
18
A
ASP
8
-81.94
41.47
18
A
ASN
35
-81.10
36.71
18
A
ASN
36
64.48
-73.15
18
A
ASN
37
177.37
36.05
18
A
LYS
48
-83.86
43.42
18
A
ASP
52
-177.04
-53.75
18
A
LYS
53
-74.99
-147.00
18
B
THR
12
-107.18
76.29
18
B
SER
20
-93.76
33.28
18
B
ASP
21
-90.83
-123.74
18
B
LYS
33
-70.72
-72.10
18
B
GLN
40
-78.55
34.33
18
B
ALA
46
68.66
-65.81
19
A
PRO
21
-78.36
44.58
19
A
ALA
22
-170.60
41.79
19
A
ASN
35
-64.86
-78.26
19
A
ASN
36
166.96
38.00
19
A
LYS
48
-88.11
42.21
19
A
ASP
52
-175.75
137.26
19
B
ASP
21
-91.36
-134.73
19
B
GLN
62
-79.54
-157.31
19
B
ARG
74
-79.50
45.45
20
A
ASP
7
-145.54
-33.53
20
A
ASP
8
-75.63
39.35
20
A
ALA
22
-168.45
-45.24
20
A
ASN
35
-79.27
38.77
20
A
LYS
48
-83.24
43.14
20
A
ASN
50
-170.69
55.80
20
A
ASP
51
-64.77
-137.80
20
B
SER
20
-90.31
35.10
20
B
ASP
21
-78.22
-130.78
20
B
THR
22
-176.93
139.41
20
B
LYS
48
-172.55
145.56
20
B
ARG
74
51.87
-133.78
Solution Structure of a CUE-Ubiquitin Complex
1
N
N
2
N
N
A
HIS
9
A
HIS
4
HELX_P
A
MET
19
A
MET
14
1
1
11
A
LYS
25
A
LYS
20
HELX_P
A
GLU
34
A
GLU
29
1
2
10
A
LEU
39
A
LEU
34
HELX_P
A
LEU
47
A
LEU
42
1
3
9
B
ILE
23
B
ILE
23
HELX_P
B
GLU
34
B
GLU
34
1
4
12
B
LEU
56
B
LEU
56
HELX_P
B
TYR
59
B
TYR
59
1
5
4
CELL CYCLE
PROTEIN-PROTEIN COMPLEX, CELL CYCLE
CUE2_YEAST
UNP
1
6
P36075
NDDHESKLSILMDMFPAISKSKLQVHLLENNNDLDLTIGLLLKENDDKS
UBIQ_YEAST
UNP
2
1
P61864
MQIFVKTLTGKTITLEVESSDTIDNVKSKIQDKEGIPPDQQRLIFAGKQLEDGRTLSDYNIQKESTLHLVLRLRGG
6
54
1OTR
6
54
P36075
A
1
1
49
1
76
1OTR
1
76
P61864
B
2
1
76
5
anti-parallel
parallel
anti-parallel
anti-parallel
B
THR
12
B
THR
12
B
GLU
16
B
GLU
16
B
GLN
2
B
GLN
2
B
THR
7
B
THR
7
B
THR
66
B
THR
66
B
LEU
71
B
LEU
71
B
GLN
41
B
GLN
41
B
PHE
45
B
PHE
45
B
LYS
48
B
LYS
48
B
GLN
49
B
GLN
49